Findings

What do systematic reviews say?

23 questions · 23 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 9 · 39.1%GRADE not reported 0 · 0%Very low 3 · 13%Low 4 · 17.4%Moderate 3 · 13%High 4 · 17.4%

Summary of findings: intravitreal bevacizumab plus intravitreal steroid vs intravitreal steroid

Quality of life at · adults with centre‐involving diabetic macular oedema

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: intravitreal bevacizumab plus intravitreal steroid vs macular laser

Change in visual acuity (logMAR) ‐ 12 months (negative is better) · adults with centre‐involving diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Summary of findings: intravitreal bevacizumab plus intravitreal steroid vs macular laser

Gain or loss of 10 or more letters visual acuity at 1 year · adults with centre‐involving diabetic macular oedema

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found